The United States Federal Department of Transportation (DOT) made a final ruling Thursday, November 9, 2017, on the proposed rules to include opioids in their drug testing program. Originally proposed in January of 2017, the ruling is now final and will go into effect on January 1, 2018. The DOT drug testing program will now include testing for hydrocodone, hydromorphone, oxymorphone, and oxycodone.
As a DOT client of CannAmm, no action is necessary on your part. CannAmm will ensure compliance with these guidelines.
US DOT testing is often seen as a standard to be met or exceeded in non-DOT situations. In light of this, CannAmm is working with various stakeholders to determine the impact on industry testing standards. Currently, there are no changes planned but discussions pertaining to testing standards are constantly evolving. CannAmm will diligently work with industry stakeholders in order to keep our clients informed.
